n(g),n(g')-dimethyl-l-arginine has been researched along with Diabetic Retinopathy in 7 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the meta-analysis was to evaluate the relationship between serum asymmetric dimethylarginine (ADMA) level and microvascular complications in diabetes mellitus (DM) including diabetic retinopathy (DR), diabetic neuropathy (DN), and diabetic nephropathy." | 9.01 | Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis. ( Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P, 2019) |
| "The purpose of the meta-analysis was to evaluate the relationship between serum asymmetric dimethylarginine (ADMA) level and microvascular complications in diabetes mellitus (DM) including diabetic retinopathy (DR), diabetic neuropathy (DN), and diabetic nephropathy." | 5.01 | Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis. ( Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P, 2019) |
| "Patients with type 2 diabetes and diabetic microvascular complications have significantly elevated levels of Asymmetric dimethylarginine (ADMA), which is an endogenous inhibitor of nitric oxide synthase (NOS)." | 3.01 | Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus. ( Guo, X; Jin, W; Xing, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X | 1 |
| Xing, Y | 1 |
| Jin, W | 1 |
| Huang, CY | 1 |
| Zhou, T | 2 |
| Li, G | 1 |
| Li, MY | 1 |
| Xiong, XM | 1 |
| Wu, MT | 1 |
| Jiang, JL | 2 |
| Jayachandran, I | 1 |
| Sundararajan, S | 1 |
| Venkatesan, S | 1 |
| Paadukaana, S | 1 |
| Balasubramanyam, M | 1 |
| Mohan, V | 1 |
| Manickam, N | 1 |
| Du, MR | 1 |
| Yan, L | 1 |
| Li, NS | 1 |
| Wang, YJ | 1 |
| Liu, J | 1 |
| Li, C | 1 |
| Chen, W | 1 |
| He, K | 1 |
| Ma, H | 1 |
| Ma, B | 1 |
| Zhao, P | 1 |
| Tian, L | 1 |
| Simó-Servat, O | 1 |
| Simó, R | 1 |
| Hernández, C | 1 |
| Chen, Y | 1 |
| Xu, X | 1 |
| Sheng, M | 1 |
| Zhang, X | 1 |
| Gu, Q | 1 |
| Zheng, Z | 1 |
3 reviews available for n(g),n(g')-dimethyl-l-arginine and Diabetic Retinopathy
| Article | Year |
|---|---|
Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Huma | 2023 |
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis.
Topics: Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; D | 2019 |
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.
Topics: Adrenomedullin; Arginine; Autoantibodies; Basement Membrane; Biomarkers; C-Reactive Protein; Collage | 2016 |
4 other studies available for n(g),n(g')-dimethyl-l-arginine and Diabetic Retinopathy
| Article | Year |
|---|---|
Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
Topics: Animals; Apoptosis; Arginine; Blood-Retinal Barrier; Cell Communication; Cell Membrane Permeability; | 2019 |
Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway.
Topics: Animals; Arginine; Cell Line; Cell Movement; Cell Proliferation; Cells, Cultured; Diabetic Retinopat | 2020 |
Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway.
Topics: Amidohydrolases; Animals; Arginine; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Diabet | 2018 |
PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Cells, Cultured; Cyclic GMP; Diabetes Mellitu | 2009 |